April 2 (Reuters) - Curanex Pharmaceuticals Inc CURX.O:
CURANEX PHARMACEUTICALS INC - EXPANDS DRUG DEVELOPMENT PIPELINE - SEC FILING
CURANEX PHARMACEUTICALS INC - TO FOCUS ON CANCER CACHEXIA AS NEW CORE INDICATION - SEC FILING
Source text: [ID:n0001493152-26-014815]